Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells

Immunity

Volumn 7, Issue 6, 1997, Pages 885-895

  Chambers, Cynthia A ^a   Sullivan, Timothy J ^a   Allison, James P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN G ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031405867     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80406-9     Document Type: Article

References (63)

1. Alegre, M.-L., Noel, P.J., Eisfelder, B.J., Chuang, E., Clark, M.R., Reiner, S.L., and Thompson, C.B. (1996). Regulation of surface and intracellular expression of CTLA-4 on mouse T cells. J. Immunol. 157, 4762-4770.
2. Allison, J.P., Havran, W.L., Poenie, M., Kimura, J., Degraffenreid, L., Ajami, S., Duwe, G., Weiss, A., and Tsien, R. (1987). Expression and function of CD3 on murine thymocytes. In The T Cell Receptor: UCLA Symposia on Molecular and Cellular Biology, New Series, J. Kappler and M. Davis, eds. (New York: Alan R. Liss), pp. 33-45.
3. Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H., and Lanier, L.L. (1992). CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175, 353-360.
4. Borriello, F., Sethna, M.P., Boyd, S.D., Schweitzer, A.N., Tivol, E.A., Jacoby, D., Strom, T.B., Simpson, E.M., Freeman, G.J., and Sharpe, A.M. (1997). B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303-313.
5. Brunet, J.-F., Denizot, F., Luciani, M.-F., Roux-Dosseto, M., Suzan, M., Mattei, M.-G., and Golstein, P. (1987). A new member of the immunoglobulin superfamily: CTLA-4. Nature 320, 267-270.
6. Campbell, R.S., Buder, A., and Deuschle, U. (1995). Interactions between the amino-terminal domain of p56lck and cytoplasmic domains of CD4 and CD8 alpha in yeast. Eur. J. Immunol. 25, 2408-2412.
7. Chace, J.H., Cowdery, J.S., and Field, E.H. (1994). Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J. Immunol. 152, 405-412.
8. Chambers, C.A., and Allison, J.P. (1997). Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396-404.
9. Chambers, C.A., Cado, D., Truong, T., and Allison, J.P. (1997). Thymocyte differentiation is normal in the CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94, 9296-9301.
10. Chambers, C.A., Krummel, M.F., Boitel, B., Hurwitz, A.A., Sullivan, T.J., Fournier, S., Cassell, D., Brunner, M., and Allison, J.P. (1996). The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev. 153, 27-46.
11. Chuang, E., Alegre, M.-L., Duckett, C.S., Noel, P.J., Vander Heiden, M.G., and Thompson, C.B. (1997). Interaction of CTLA-4 with the clathrin-associated protein AP-50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 159, 144-151.
12. + T cells. Eur. J. Immunol. 27, 598-608.
13. Dialynas, O.P., Quan, Z.S., Wall, K.A., Pierres, A., Quintans, J., Loken, M.R., Pierres, M., and Fitch, F.W. (1983). Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131, 2445-2451.
14. Finck, B.K., Linsley, P.S., and Wofsy, D. (1994). Treatment of murine lupus with CTLA-4lg. Science 265, 1225-1227.
15. Finn, P.W., He, W., Wang, Y., Wang, Z., Guan, G., Listman, J., and Perkins, D.L. (1997). Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J. Immunol. 158, 4074-4081.
16. Fournier, S., Rathwell, J., Goodnow, C., and Allison, J.P. (1997). T cell-mediated elimination of B7.2 transgenic B cells. Immunity 6, 327-339.
17. Freeman, G.J., Lombard, D.B., Gimmi, C.D., Brod, S.A., Lee, K., Laning, J.C., Hafler, D.A., Dorf, M.E., Gray, G.S., Reiser, H., et al. (1992). CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Evidence of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 149, 3795-3801.
18. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177, 1791-1796.
19. Harding, F.A., McArthur, J.G., Gross, J.A., Raulet, D.H., and Allison, J.P. (1992). CD28-mediated signaling costimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607-609.
20. Hurwitz, A.A., Sullivan, T.J., Krummel, M.F., Sobel, R.A., and Allison, J.P. (1996). Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histological disease in an actively-induced model of experimental allergic encephalomyelitis. J. Neuroimmunol. 73, 57-62.
21. Janeway, C.A., and Bottomly, K. (1994). Signals and signs for lymphocyte responses. Cell 76, 275-285.
22. Karandikar, N.J., Vanderlugt, C.L., Walunas, T.L., Miller, S.D., and Bluestone, J.A. (1996). CTLA-4: a negative regulator of autoimmune diseases. J. Exp. Med. 184, 783-788.
23. + T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155, 1032-1036.
24. Kronin, V., Winkel, K., Süss, G., Kelso, A., Heath, W., Kirberg, J., von Boehmer, H., and Shortman, K. (1996). A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production. J. Immunol. 157, 3819-3827.
25. Krummel, M.F., and Allison, J.P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459-465.
26. Krummel, M.F., and Allison, J.P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533-2540.
27. Krummel, M.F., Sullivan, T.J., and Allison, J.P. (1996). Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 8, 519-523.
28. Kubo, R.T., Born, W., Kappler, J.W., Marrack, P. and Pigeon, M. (1989). Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142, 2736-2742.
29. Kuiper, H., Brouwer, M., Linsley, P.S., and van Lier, R.A.W. (1995). Activated T cells can induce high levels of CTLA-4 expression on B cells. J. Immunol. 155, 1776-1783.
30. Kwon, E.D., Hurwitz, A.A., Foster, B.A., Madias, C., Feldhaus, A.L., Greenberg, N.M., Burg, M.B., and Allison, J.P. (1997). Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA 94, 8099-8103.
31. + T cells. J. Exp. Med. 179, 819-830.
32. Leach, D.R., Krummel, M.F., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736.
33. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. (1996). CD28/ B7 system of T cell costimulation. Ann. Rev. Immunol. 14, 233-258.
34. Leung, H.T., Bradshaw, J., Cleaveland, J.S., and Linsley, P.S. (1995). Cytotoxic T lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 270, 1-8.
35. Linsley, P.S., Bradshaw, J., Greene, J., Peach, R., Bennett, K.L., and Mittler, R.S. (1996). Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4, 535-543.
36. Linsley, P.S., and Ledbetter, J.A. (1993) The role of the CD28 receptor during T cell responses to antigen. Ann. Rev. Immunol. 11, 191-212.
37. Linsley, P.S., Wallace, P.M., Johnson, J., Gibson, M.G., Green, J.L., Ledbetter, J.A., Singh, C., and Tepper, M.A. (1992). Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792-795.
38. Luo, K., and Sefton, B.M. (1990). Cross-linking of T-cell surface molecules CD4 and CD8 stimulates phosphorylation of the lck tyrosine protein kinase at the autophosphorylation site. Mol. Cell. Biol. 10, 5305-5313.
39. Madrenas, J., Chau, L.A., Smith, J., Bluestone, J.A., and Germain, R.N. (1997). The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185, 219-229.
40. + primary T cells. Eur. J. Immunol. 24, 967-973.
41. Perkins, D., Wang, Z., Donovan, C., He, H., Mark, D., Guan, G., Wang, Y., Walunase, T., Bluestone, J., and Listman, J.E.A. (1996). Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156, 4154-4159.
42. Perrin, P.J., Maldonado, J.H., Davis, T.A., June, C.H., and Racke, M.K. (1996). CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157, 1333-1336.
43. Perrin, P.J., Scott, L., Quigley, L., Albert, P.S., Feder, P., Gray, G.S., Abe, R., June, C.H., and Racke, M.K. (1995). Role of B7:CTLA-4 in the induction of chronic relapsing experimental allergi encephalomyelitis. J. Immunol. 15, 1481-1490.
44. Ravichandran, K.S., and Burakoff, S.J. (1994). Evidence for differential intracellular signaling via CD4 and CD8 molecules. J. Exp. Med. 179, 727-732.
45. Sarmiento, M., Glasebrook, S., and Fitch, F.W. (1980). IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125, 2665-2672.
46. Shiratori, T., Miyatake, S., Ohno, H., Nakaseko, C., Isono, K., Bonifacino, J.S., and Saito, T. (1997). Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6, 583-589.
47. Sloan-Lancaster, J., Evavold, B.D., and Allen, P.M. (1993). Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363, 156-159.
48. Sprent, J., and Tough, D.F. (1994). Lymphocyte life-span and memory. Science 265, 1395-1400.
49. + T cells but affect their long-term life span. Immunity 5, 217-228.
50. Tanchot, C., Lemonnier, F.A., Pérarnau, B., Freitas, A.A., and Rocha, B. (1997). Differential requirements for survival and proliferation of CD8 naive or memory cells. Science 276, 2057-2062.
51. Thompson, C.B., and Allison, J.P. (1997). The emerging role of CTLA-4 as an immune attenuator, Immunity 7, 445-450.
52. Tivol, E., Boyd, S.D., McKeon, S., Borriello, F., Nickerson, P., Strom, T.B., and Sharpe, A. (1997). CTLA-4lg prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 158, 5091-5094.
53. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role for CTLA-4. Immunity 3, 541-546.
54. Tough, D.F., and Sprent, J. (1994). Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179, 1127-1135.
55. Townsend, S.E., Su, F.W., Atherton, J.M., and Allison, J.P. (1994). Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.
56. Veillette, A., Bookman, M.A., Horak, E.M., and Bolen, J.B. (1988). The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine kinase p56lck. Cell 53, 301-308.
57. Veillette, A., Züniga-Pflücker, J.C., Bolen, J.B., and Kruisbeek, A.M. (1989). Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways. J. Exp. Med. 170, 1671-1680.
58. Vidal, K., Hsu, B.L., Williams, C.B., and Allen, P.M. (1996). Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183, 1311-1321.
59. Walunas, T.L., Bakker, C.Y., and Bluestone, J.A. (1996). CTLA-4-ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541-2550.
60. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
61. Waterhouse, P., Marengére, L.E.M., Mittrücker, H.-W., and Mak, T.W. (1996). CTLA-4, a negative regulator of T-lymphocyte activation, Immunol. Rev. 153, 183-207.
62. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shanhinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). CTLA-4 deficiency causes lymphoproliferative disorder with early lethality. Science 270, 985-988.
63. Zhang, Y., and Allison, J.P. (1997). Interaction of CTLA-4 with AP-50, aclathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. USA 94, 9273-9278.